Macrogen

Macrogen Current Liabilities

The Current Liabilities of Macrogen (038290.KQ) as of Oct 29, 2026 is 10.09 B KRW. In the previous year, Current Liabilities was 74.25 B KRW — a change of -86.41% (lower).

Current Liabilities

10.09 BKRW

YoY

-86.41%

Last updated:

Current Liabilities of Macrogen is 2025 10.09 B KRW. Current Liabilities of Macrogen was 2024 74.25 B KRW. It decreases by -86.41% lower compared to the previous year.

The Macrogen Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
59.44 B KRW
Jan 1, 2019
84.60 B KRW
Jan 1, 2020
58.05 B KRW
Jan 1, 2021
76.55 B KRW
Jan 1, 2022
26.13 B KRW
Jan 1, 2023
20.94 B KRW
Jan 1, 2024
74.25 B KRW
Jan 1, 2025
10.09 B KRW
The Macrogen Current Liabilities history
YEARCurrent LiabilitiesYoY
10.09 BKRW-86.41%
74.25 BKRW+254.60%
20.94 BKRW-19.88%
26.13 BKRW-65.86%
76.55 BKRW+31.87%
58.05 BKRW-31.39%
84.60 BKRW+42.34%
59.44 BKRW-29.21%
83.97 BKRW+27.73%
65.74 BKRW+165.46%
24.76 BKRW-48.07%
47.68 BKRW+86.76%
25.53 BKRW+93.26%
13.21 BKRW+22.60%
10.78 BKRW+93.92%
5.56 BKRW-55.50%
12.49 BKRW+399.16%
2.50 BKRW+35.17%
1.85 BKRW+21.30%
1.53 BKRW-27.71%
2.11 BKRW+26.03%
1.68 BKRW+47.45%
1.14 BKRW-56.02%
2.58 BKRW+103.07%
1.27 BKRW+47.91%
860.00 MKRW+77.69%
484.00 MKRW+476.19%
84.00 MKRW+281.82%
22.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Macrogen Stock analysis

What does Macrogen do? Macrogen Inc. generates revenue through its four business divisions. The DNA sequencing division provides genome sequencing analysis services to clients requiring genetic data processing. The DNA chips division sells products including Illumina chips, MacArray chips, and customized chips to research institutions and biotech firms. The transgenic and knockout mouse division offers gene engineering services to pharmaceutical companies and academic laboratories. The oligonucleotide DNA division supplies oligonucleotide DNA manufacturing services to biotechnology clients. All services are delivered domestically and internationally to established market segments. The company's DNA chips division markets specific branded products like Illumina chips and MacArray chips, which are purchased by research organizations and biotechnology enterprises. Gene engineering services from the transgenic division are bought by pharmaceutical companies seeking to develop new treatments. Oligonucleotide DNA manufacturing services target biotech clients needing specialized DNA synthesis. Domestic and overseas markets represent the primary customer segments for all divisions. Macrogen's product portfolio includes DNA sequencing services, DNA chip products, gene engineering solutions, and oligonucleotide DNA manufacturing. Clients include research institutions, pharmaceutical companies, academic laboratories, and biotechnology firms. The DNA chips division's branded products are specifically named in the description, while other services are described by their technical functions. Market segments are defined by the company's domestic and international operations. Macrogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Macrogen stock

Current Liabilities of Macrogen is 10.09 B KRW in 2025.

Current Liabilities of Macrogen changed from 74.25 B KRW to 10.09 B KRW, representing a -86.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Macrogen since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Macrogen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Macrogen

All Key Metrics — Macrogen